| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14740338.4.5.849 |
| P698 | PubMed publication ID | 16111448 |
| P50 | author | Heinz Grunze | Q38642623 |
| Florian Seemüller | Q41595364 | ||
| P2093 | author name string | Anna Forsthoff | |
| W Emanuel Severus | |||
| Sandra Dittmann | |||
| Christoph Born | |||
| Britta Bernhard | |||
| P2860 | cites work | Selection of atypical antipsychotics for the management of schizophrenia | Q31037993 |
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp | Q34283069 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania | Q34531273 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment | Q34550618 | ||
| Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania | Q34552561 | ||
| Height, weight and body mass index (BMI) in psychiatrically ill US Armed Forces personnel | Q35012793 | ||
| Waist circumference, visceral obesity, and cardiovascular risk | Q35143574 | ||
| Management of bipolar disorder during pregnancy and the postpartum period | Q35729488 | ||
| Aripiprazole: in acute mania associated with bipolar I disorder | Q35747870 | ||
| Updating the evidence that physical activity is good for health: an epidemiological review 2000-2003. | Q35815635 | ||
| Side effects of atypical antipsychotic drugs | Q35849629 | ||
| Olanzapine: a review of its use in the management of bipolar I disorder | Q35945257 | ||
| Mood-altering effects of biperiden in healthy volunteers | Q41854315 | ||
| Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
| Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 | ||
| Lamotrigine and the risk of malformations in pregnancy | Q43669569 | ||
| Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy | Q43846648 | ||
| Olanzapine versus divalproex in the treatment of acute mania | Q44013092 | ||
| Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo. | Q44018213 | ||
| Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 | ||
| Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 | ||
| Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone | Q44824135 | ||
| Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study | Q44874572 | ||
| Burden of general medical conditions among individuals with bipolar disorder | Q45070754 | ||
| Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol | Q45168624 | ||
| Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey | Q45236718 | ||
| Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs | Q45285400 | ||
| Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium | Q45297000 | ||
| Kaplan Award 1998. Epidemiology of chronic daily headache in the general population | Q48345830 | ||
| Effects of exercise training on older patients with major depression. | Q51084834 | ||
| The associations between psychopathology and being overweight: a 20-year prospective study. | Q51935503 | ||
| Prevalence, Clinical Correlates, and Treatment of Migraine in Bipolar Disorder | Q51946593 | ||
| Cross-national epidemiology of major depression and bipolar disorder | Q57150744 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 849-868 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Expert Opinion on Drug Safety | Q5421206 |
| P1476 | title | The safety and tolerability of atypical antipsychotics in bipolar disorder | |
| P478 | volume | 4 |
| Q36945015 | Off-label use of antipsychotics: are we mad? |
| Q37790388 | Paliperidone extended-release: a review of efficacy and tolerability in schizophrenia, schizoaffective disorder and bipolar mania |
| Q44017165 | Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania |
| Q34649187 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder |
| Q37076060 | The neuropharmacology of psychosis |
| Q39888212 | The return of fixed combinations in psychiatry: fluoxetine and olanzapine combination |
| Q36687060 | Treatment of psychosis: 30 years of progress. |
| Q40116422 | Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats |
Search more.